Nasdaq:US$38.93 (+1.39) | HKEX:HK$60.10 (+0.40) | AIM:£5.56 (+0.14)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
What We Do
Overview
Research and Development
Commercialization
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Presentations
Recent News
Announcement & Press Releases
Presentations & Publications
Mailing List Sign-up
Shareholder Information
Overview
Events, Circulars & Forms
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
Careers
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
What We Do
Overview
Research and Development
Commercialization
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Presentations
Recent News
Announcement & Press Releases
Presentations & Publications
Mailing List Sign-up
Shareholder Information
Overview
Events, Circulars & Forms
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
Careers
Shareholder Information
Hutchmed
| Shareholder Information
SHARE PRICE CHART
Nasdaq:HCM
US$38.93
+1.39 | 17 Sep 2021 | 16:41EDT
Market cap (M): US$6,729.96
HKEX:13
HK$60.10
+0.4 | 17 Sep 2021 | 16:08HKT
Market cap (M): HK$51,948.46
London AIM:HCM
£5.56
+0 | 17 Sep 2021 | 16:38BST
Market cap (M): £4,805.88
MAJOR SHAREHOLDERS
Directors and Significant Shareholders
Financial Reports
Annual Reports (with 20-F) and Interim Reports
Announcement & Press Releases
EVENTS, CIRCULARS AND FORMS
Jefferies Asia Forum
2021-09-08
Chinese Society of Clinical Oncology 2021 Annual Meeting
2021-09-25 - 2021-09-29
ESMO Congress 2021
2021-09-16 - 2021-09-21
Morgan Stanley Virtual Global Healthcare Conference
2021-09-09
Information for Shareholders
Share-related address & contact information
DUAL-LISTING FAQS
Frequently asked questions about HUTCHMED's UK and US share listings
SEC Filings
AIM RULE 26 DISCLOSURES
Disclosure reference pursuant to Rule 26 'Company Information' of the AIM Rules of Companies
Warning to Shareholders
Avoiding share fraud
Analyst Coverage
Bloomberg
Cantor Fitzgerald
Goldman Sachs
Barclays
Bank of America Merrill Lynch
Canaccord Genuity
CLSA
Deutsche Bank
Edison
HSBC
Macquarie
Morgan Stanley
Panmure Gordon
Trinity Delta